Does OFATUMUMAB Cause Hepatitis b? 19 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 19 reports of Hepatitis b have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.1% of all adverse event reports for OFATUMUMAB.
19
Reports of Hepatitis b with OFATUMUMAB
0.1%
of all OFATUMUMAB reports
6
Deaths
6
Hospitalizations
How Dangerous Is Hepatitis b From OFATUMUMAB?
Of the 19 reports, 6 (31.6%) resulted in death, 6 (31.6%) required hospitalization, and 3 (15.8%) were considered life-threatening.
Is Hepatitis b Listed in the Official Label?
Yes, Hepatitis b is listed as a known adverse reaction in the official FDA drug label for OFATUMUMAB.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Hepatitis b?
RITUXIMAB (597)
CYCLOPHOSPHAMIDE (578)
LAMIVUDINE (480)
DOXORUBICIN (469)
VINCRISTINE (431)
PREDNISOLONE (371)
TENOFOVIR DISOPROXIL (257)
PREDNISONE (208)
DEXAMETHASONE (173)
ENTECAVIR (166)
Which OFATUMUMAB Alternatives Have Lower Hepatitis b Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB